 CAMBRIDGE, Mass., March 16, 2021 PRNewswire -- Synlogic, Inc. NASDAQ: SYBX, a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the Company will release its fourth quarter and full year 2020 financial results before the market opens on Thursday, March 25, 2021. 